This has already been suggested by Mannisto and colleagues who observed that in a series of yolk sac tumors the aggressive clinical behaviour was related to the higher activity of GATA-4 in the absence of FOG-2 [22]. This evidence concerns the gene GATA4 and yolk sac tumor.